Tirdzniecība 10x Genomics, Inc. - TXG CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | 0.13 | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024068% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.001846% | ||||||||
| Nakts laika nodeva | 21:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | 48.97 |
| Atvērt* | 47.83 |
| Izmaiņas par 1 gadu* | -29.79% |
| Dienas Diapazons* | 47.71 - 50.18 |
| 52 ned Diapazons | 23.81-83.34 |
| Vidējais apjoms (10 dienas) | 923.06K |
| Vidējais apjoms (3 mēneši) | 21.45M |
| Tirgus Kapitalizācija | 5.79B |
| Cenas/Peļņas Attiecība | -100.00K |
| Izvietotās Akcijas | 115.36M |
| Ieņēmumi | 516.41M |
| EPS | -1.46 |
| Dividende (Ienesīgums %) | N/A |
| Beta | 1.73 |
| Nākamās Peļņas Datums | May 2, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 50.12 | 2.16 | 4.50% | 47.96 | 50.30 | 47.65 |
| Mar 23, 2023 | 48.97 | 0.03 | 0.06% | 48.94 | 51.49 | 48.48 |
| Mar 22, 2023 | 48.69 | -1.39 | -2.78% | 50.08 | 51.08 | 48.61 |
| Mar 21, 2023 | 50.03 | 1.83 | 3.80% | 48.20 | 50.25 | 47.91 |
| Mar 20, 2023 | 47.76 | 0.30 | 0.63% | 47.46 | 48.56 | 46.76 |
| Mar 17, 2023 | 48.08 | -1.09 | -2.22% | 49.17 | 49.71 | 47.66 |
| Mar 16, 2023 | 50.25 | 2.49 | 5.21% | 47.76 | 50.90 | 47.60 |
| Mar 15, 2023 | 48.54 | 1.45 | 3.08% | 47.09 | 49.32 | 47.08 |
| Mar 14, 2023 | 48.63 | 0.07 | 0.14% | 48.56 | 49.52 | 48.06 |
| Mar 13, 2023 | 47.44 | 3.47 | 7.89% | 43.97 | 49.32 | 43.97 |
| Mar 10, 2023 | 44.93 | -1.55 | -3.33% | 46.48 | 46.49 | 43.15 |
| Mar 9, 2023 | 47.00 | -1.65 | -3.39% | 48.65 | 49.98 | 46.93 |
| Mar 8, 2023 | 48.95 | 1.16 | 2.43% | 47.79 | 49.49 | 47.24 |
| Mar 7, 2023 | 48.16 | 0.10 | 0.21% | 48.06 | 49.75 | 47.48 |
| Mar 6, 2023 | 48.39 | -2.30 | -4.54% | 50.69 | 50.80 | 48.13 |
| Mar 3, 2023 | 50.95 | 2.70 | 5.60% | 48.25 | 51.11 | 48.20 |
| Mar 2, 2023 | 48.18 | 2.88 | 6.36% | 45.30 | 48.71 | 45.06 |
| Mar 1, 2023 | 46.58 | -1.34 | -2.80% | 47.92 | 47.94 | 45.58 |
| Feb 28, 2023 | 47.49 | 0.83 | 1.78% | 46.66 | 49.22 | 46.66 |
| Feb 27, 2023 | 47.66 | 0.24 | 0.51% | 47.42 | 48.15 | 46.58 |
10x Genomics, Inc. Events
| Laiks (UTC) (UTC) | Valsts | Notikums |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 490.49 | 298.845 | 245.893 | 146.313 | 71.085 |
| Ienākumi | 490.49 | 298.845 | 245.893 | 146.313 | 71.085 |
| Cost of Revenue, Total | 74.091 | 58.468 | 61.033 | 28.661 | 10.56 |
| Bruto Peļņa | 416.399 | 240.377 | 184.86 | 117.652 | 60.525 |
| Kopējie Darbības Izdevumi | 542.743 | 834.508 | 276.466 | 257.077 | 89.46 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 257.56 | 199.726 | 130.834 | 87.936 | 46.736 |
| Pētniecība un Attīstība | 211.752 | 570.923 | 83.097 | 109.9 | 32.164 |
| Other Operating Expenses, Total | -0.66 | 1.27 | 1.502 | 30.58 | 0 |
| Darbības Izdevumi | -52.253 | -535.663 | -30.573 | -110.764 | -18.375 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -0.66 | -0.15 | -0.274 | -1.385 | -0.503 |
| Citi, Neto | -0.802 | 1.337 | -0.186 | -0.249 | 0.137 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -53.715 | -534.476 | -31.033 | -112.398 | -18.741 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Ārkārtas Posteņi Kopā | 0 | ||||
| Neto Ienākumi | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Atšķaidītie Neto Ienākumi | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Atšķaidītie Ienākumi par Akcijām | 110.348 | 101.152 | 39.0914 | 93.8497 | 93.8497 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.52763 | -5.36552 | -0.79943 | -1.19857 | -0.19992 |
| Atšķaidītā Normalizētā Peļņa par Akciju | -0.52763 | -5.33904 | -0.79943 | -1.19857 | -0.19992 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 4.121 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 114.496 | 143.53 | 125.297 | 115.842 | 105.821 |
| Ienākumi | 114.496 | 143.53 | 125.297 | 115.842 | 105.821 |
| Cost of Revenue, Total | 25.478 | 27.598 | 24.518 | 4.915 | 17.06 |
| Bruto Peļņa | 89.018 | 115.932 | 100.779 | 110.927 | 88.761 |
| Kopējie Darbības Izdevumi | 156.231 | 159.36 | 141.176 | 126.17 | 116.037 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 66.675 | 69.877 | 62.076 | 68.503 | 55.704 |
| Pētniecība un Attīstība | 64.078 | 61.885 | 54.582 | 53.402 | 41.883 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 0 | 0.2 | 1.2 | |
| Other Operating Expenses, Total | 0 | 0 | 0 | -0.85 | 0.19 |
| Darbības Izdevumi | -41.735 | -15.83 | -15.879 | -10.328 | -10.216 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 0.441 | -0.168 | -0.17 | -0.151 | -0.171 |
| Citi, Neto | -0.4 | 0.005 | -0.599 | 0.521 | -0.729 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -41.694 | -15.993 | -16.648 | -9.958 | -11.116 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Neto Ienākumi | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Atšķaidītie Neto Ienākumi | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 |
| Atšķaidītie Ienākumi par Akcijām | 112.966 | 111.913 | 110.874 | 109.866 | 108.714 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.37545 | -0.16485 | -0.15487 | -0.1006 | -0.10625 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Atšķaidītā Normalizētā Peļņa par Akciju | -0.37545 | -0.16485 | -0.15487 | -0.09941 | -0.09908 |
- Ikgadējs
- Ceturkšņa
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 747.591 | 774.366 | 480.84 | 106.236 | 68.107 |
| Nauda un Īstermiņa Ieguldījumi | 587.447 | 663.603 | 424.166 | 65.08 | 47.857 |
| Nauda un Ekvivalenti | 587.447 | 663.603 | 424.166 | 65.08 | 47.857 |
| Debitoru Parādu Kopsumma, Neto | 85.254 | 51.208 | 33.371 | 29.566 | 13.341 |
| Accounts Receivable - Trade, Net | 85.254 | 51.208 | 33.371 | 28.088 | 13.341 |
| Total Inventory | 59.966 | 29.959 | 15.27 | 8.57 | 4.838 |
| Prepaid Expenses | 13.896 | 13.029 | 8.033 | 3.02 | 2.071 |
| Total Assets | 1018.83 | 929.341 | 605.923 | 124.31 | 75.609 |
| Property/Plant/Equipment, Total - Net | 230.41 | 119.823 | 48.821 | 11.127 | 6.925 |
| Property/Plant/Equipment, Total - Gross | 279.431 | 150.325 | 67.876 | 25.21 | 17.958 |
| Accumulated Depreciation, Total | -49.021 | -30.502 | -19.055 | -14.083 | -11.033 |
| Other Long Term Assets, Total | 10.917 | 12.798 | 76.262 | 6.947 | 0.577 |
| Total Current Liabilities | 110.357 | 118.126 | 63.049 | 32.362 | 22.141 |
| Accounts Payable | 17.351 | 4.709 | 13.028 | 8.792 | 5.443 |
| Accrued Expenses | 75.821 | 92.326 | 30.035 | 12.118 | 8.959 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 9.882 | 4.187 | 4.224 | |
| Other Current Liabilities, Total | 17.185 | 21.091 | 10.104 | 7.265 | 3.515 |
| Total Liabilities | 201.258 | 190.269 | 185.84 | 101.053 | 29.704 |
| Total Long Term Debt | 0 | 0 | 19.837 | 25.489 | 6.335 |
| Long Term Debt | 0 | 19.837 | 25.489 | 6.335 | |
| Other Liabilities, Total | 90.901 | 72.143 | 102.954 | 43.202 | 1.228 |
| Total Equity | 817.568 | 739.072 | 420.083 | 23.257 | 45.905 |
| Redeemable Preferred Stock | 0 | 243.244 | 158.414 | ||
| Common Stock | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 |
| Additional Paid-In Capital | 1680.86 | 1544.22 | 682.494 | 11.165 | 6.136 |
| Retained Earnings (Accumulated Deficit) | -863.321 | -805.098 | -262.367 | -231.116 | -118.631 |
| Other Equity, Total | 0.022 | -0.05 | -0.046 | -0.037 | -0.015 |
| Total Liabilities & Shareholders’ Equity | 1018.83 | 929.341 | 605.923 | 124.31 | 75.609 |
| Total Common Shares Outstanding | 112.515 | 108.486 | 96.2416 | 93.8497 | 93.8497 |
| Other Current Assets, Total | 1.028 | 16.567 | |||
| Intangibles, Net | 25.397 | 22.354 | |||
| Goodwill, Net | 4.511 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 697.335 | 747.591 | 744.104 | 757.174 | 745.716 |
| Nauda un Īstermiņa Ieguldījumi | 539.323 | 587.447 | 600.44 | 621.958 | 617.195 |
| Nauda un Ekvivalenti | 312.487 | 587.447 | 600.44 | 621.958 | 617.195 |
| Debitoru Parādu Kopsumma, Neto | 76.526 | 85.254 | 78.43 | 59.68 | 57.408 |
| Accounts Receivable - Trade, Net | 76.526 | 85.254 | 78.43 | 59.68 | 57.408 |
| Total Inventory | 63.697 | 59.966 | 51.141 | 44.087 | 38.507 |
| Prepaid Expenses | 17.762 | 13.896 | 14.065 | 13.298 | 14.442 |
| Other Current Assets, Total | 0.027 | 1.028 | 0.028 | 18.151 | 18.164 |
| Total Assets | 1003.25 | 1018.83 | 990.572 | 977.579 | 954.033 |
| Property/Plant/Equipment, Total - Net | 265.88 | 230.41 | 203.304 | 176.454 | 163.666 |
| Property/Plant/Equipment, Total - Gross | 279.431 | 247.698 | 215.665 | 198.415 | |
| Accumulated Depreciation, Total | -49.021 | -44.394 | -39.211 | -34.749 | |
| Goodwill, Net | 4.511 | 4.511 | 4.511 | 4.511 | 4.511 |
| Intangibles, Net | 24.764 | 25.397 | 26.041 | 26.693 | 27.342 |
| Other Long Term Assets, Total | 10.761 | 10.917 | 12.612 | 12.747 | 12.798 |
| Total Current Liabilities | 94.446 | 110.357 | 100.375 | 113.126 | 120.549 |
| Accounts Payable | 18.956 | 17.351 | 17.037 | 16.181 | 15.578 |
| Accrued Expenses | 59.913 | 75.821 | 69.92 | 85.598 | 95.307 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 15.577 | 17.185 | 13.418 | 11.347 | 9.664 |
| Total Liabilities | 196.566 | 201.258 | 190.351 | 192.993 | 201.573 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | 0 | ||||
| Other Liabilities, Total | 102.12 | 90.901 | 89.976 | 79.867 | 81.024 |
| Total Equity | 806.685 | 817.568 | 800.221 | 784.586 | 752.46 |
| Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
| Additional Paid-In Capital | 1714.86 | 1680.86 | 1644.9 | 1612.23 | 1569.06 |
| Retained Earnings (Accumulated Deficit) | -905.734 | -863.321 | -844.872 | -827.701 | -816.649 |
| Other Equity, Total | -2.443 | 0.022 | 0.194 | 0.058 | 0.048 |
| Total Liabilities & Shareholders’ Equity | 1003.25 | 1018.83 | 990.572 | 977.579 | 954.033 |
| Total Common Shares Outstanding | 113.276 | 112.515 | 111.537 | 110.74 | 109.589 |
| Īstermiņa Ieguldījumi | 226.836 |
- Ikgadējs
- Ceturkšņa
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Nauda no Darbības | -21.373 | -217.898 | 34.627 | -76.409 | -10.699 |
| Nauda no Darbības | 21.118 | 14.012 | 7.066 | 3.905 | 4.305 |
| Bezskaidras Naudas Preces | 103.177 | 361.202 | 14.048 | 4.156 | 1.81 |
| Cash Taxes Paid | 8.66 | 0.28 | -0.022 | -0.006 | 0 |
| Samaksātie Procenti Naudā | 1.222 | 1.67 | 2.25 | 1.824 | 0.658 |
| Izmaiņas Apgrozāmajā Kapitālā | -87.445 | -50.381 | 44.764 | 28.015 | 1.948 |
| Nauda no Ieguldījumu Darbībām | -106.729 | -38.394 | -42.767 | -6.709 | -3.756 |
| Kapitālie Izdevumi | -101.278 | -38.394 | -42.767 | -6.709 | -3.756 |
| Nauda no Darbībām ar Finansēšanu | 35.297 | 468.906 | 414.59 | 105.367 | 20.583 |
| Naudas Plūsma Finansēšanas Posteņos | -5.028 | -5.848 | 0 | 0 | |
| Akciju Izsniegšana (Atkāpšanās), Neto | 40.325 | 506.01 | 414.59 | 86.628 | 20.976 |
| Parādu Izsniegšana (Atkāpšanās), Neto | 0 | -31.256 | 0 | 18.739 | -0.393 |
| Ārvalstu Valūtas Ietekme | 0.234 | -0.463 | -0.045 | -0.018 | -0.014 |
| Neto Izmaiņas Naudā | -92.571 | 212.151 | 406.405 | 22.231 | 6.114 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -5.451 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -42.413 | -58.223 | -39.774 | -22.603 | -11.551 |
| Cash From Operating Activities | -20.802 | -21.373 | -27.178 | -0.962 | -4.082 |
| Cash From Operating Activities | 6.191 | 21.118 | 15.337 | 9.641 | 4.752 |
| Non-Cash Items | 28.014 | 103.177 | 74.717 | 47.188 | 17.922 |
| Cash Taxes Paid | 2.9 | 8.66 | 8.318 | 7.838 | 6.822 |
| Cash Interest Paid | 0.841 | 1.222 | 1.222 | 1.222 | 1.222 |
| Changes in Working Capital | -12.594 | -87.445 | -77.458 | -35.188 | -15.205 |
| Cash From Investing Activities | -257.558 | -106.729 | -79.111 | -58.884 | -44.316 |
| Capital Expenditures | -28.136 | -101.278 | -73.66 | -53.433 | -38.865 |
| Other Investing Cash Flow Items, Total | -229.422 | -5.451 | -5.451 | -5.451 | -5.451 |
| Cash From Financing Activities | 2.417 | 35.297 | 26.394 | 19.711 | 3.518 |
| Financing Cash Flow Items | -5.409 | -5.028 | -5.028 | -5.028 | -5.028 |
| Issuance (Retirement) of Stock, Net | 7.826 | 40.325 | 31.422 | 24.739 | 8.546 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
| Foreign Exchange Effects | -0.018 | 0.234 | 0.316 | 0.199 | 0.193 |
| Net Change in Cash | -275.961 | -92.571 | -79.579 | -39.936 | -44.687 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| Morgan Stanley Investment Management Inc. (US) | Investment Advisor/Hedge Fund | 9.4813 | 9210082 | -415196 | 2022-12-31 | LOW |
| Baillie Gifford & Co. | Investment Advisor | 8.8556 | 8602235 | 158847 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.6523 | 8404774 | 145652 | 2022-12-31 | LOW |
| Paladin Capital Management, LLC | Investment Advisor | 8.3511 | 8112208 | 0 | 2022-03-31 | |
| ARK Investment Management LLC | Investment Advisor | 4.4437 | 4316567 | -260247 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.3422 | 4217954 | 207975 | 2022-12-31 | LOW |
| Sands Capital Management, LLC | Investment Advisor | 3.3012 | 3206783 | -184394 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 3.2549 | 3161803 | -518131 | 2022-12-31 | LOW |
| SRS Investment Management, LLC | Hedge Fund | 3.0939 | 3005427 | 0 | 2022-12-31 | LOW |
| Generation Investment Management LLP | Investment Advisor/Hedge Fund | 2.6231 | 2548100 | -57577 | 2022-12-31 | LOW |
| Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.2421 | 2177988 | -29270 | 2022-12-31 | LOW |
| Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 2.1979 | 2135038 | -17833 | 2022-12-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 2.018 | 1960300 | -337642 | 2022-12-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 1.507 | 1463901 | 1108820 | 2022-12-31 | HIGH |
| Brown Capital Management, LLC | Investment Advisor | 1.4964 | 1453630 | -161463 | 2022-12-31 | LOW |
| Foresite Capital Management, LLC | Private Equity | 1.3985 | 1358528 | -1145000 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.3854 | 1345749 | -18168 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3601 | 1321234 | 63324 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 1.2491 | 1213394 | 999487 | 2022-12-31 | HIGH |
| JP Morgan Asset Management | Investment Advisor | 1.2158 | 1180996 | 27291 | 2022-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
Tirdzniecības komisija
0
- 1:1
Finanšu svira
1:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
10x Genomics, Inc. Company profile
Par 10x Genomics, Inc.
10x Genomics, Inc. ir dzīvības zinātņu tehnoloģiju uzņēmums. Uzņēmuma integrētie risinājumi ietver instrumentus, palīgmateriālus un programmatūru bioloģisko sistēmu analīzei. Tās produktu klāstā ir šādi produkti: Chromium Single Cell Gene Expression, Single Cell Immune Profiling, Single Cell assay for transposase accessible chromatin (ATAC) + Gene Expression, Single Cell ATAC, Spatial Gene Expression, Spatial Gene Expression, Spatial Multiomics un Targeted Gene Expression. Tās instrumenti ir Chromium X Series, Chromium Connect un Chromium Controller. Tās tehnoloģija Next GEM tehnoloģija, kas ietver mikroshēmas un saderīgus reaģentus, kuri tiek piedāvāti vienas šūnas produktu portfelim. Uzņēmuma palīgmateriālu portfelis ietver mikrofluidiskās mikroshēmas, priekšmetstikliņus, reaģentus un citus palīgmateriālus gan Visium, gan Chromium risinājumiem. Uzņēmuma lietojumprogrammās ietilpst klasterizētu regulāri izkliedētu īsu palindromisko atkārtojumu (CRISPR) skrīnings, multikomponentu citometrija un imūno receptoru kartēšana.
| Industry: | Laboratory Diagnostic & Testing Substances |
6230 Stoneridge Mall Road
PLEASANTON
CALIFORNIA 94588
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com